SIX4 and colorectal carcinoma: We also proposed an eight-gene signature comprising AMH, WBSCR28, SFTA2, MYH2, POU4F1, SIX4, PGPEP1L, and PAX5, which would provide directive significance for prognostic prediction and treatment selection in CRC.